Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 3
2019 1
2020 4
2021 6
2022 8
2023 8
2024 7
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Pie diabético en México: factores de riesgo para mortalidad posterior a una amputación mayor, a 5 años, en un hospital de salud pública de segundo nivel.
Martínez-Escalante JE, Romero-Ibargüengoitia ME, Plata-Álvarez H, López-Betancourt G, Otero-Rodríguez R, Garza-Cantú AA, Corral-Guerrero ME. Martínez-Escalante JE, et al. Among authors: romero ibarguengoitia me. Cir Cir. 2021;89(3):284-290. doi: 10.24875/CIRU.20000209. Cir Cir. 2021. PMID: 34037604 Free article. English.
Viral load and its relationship with the inflammatory response and clinical outcomes in hospitalization of patients with COVID-19.
Kuri-Ayache M, Rivera-Cavazos A, Pérez-Castillo MF, Santos-Macías JE, González-Cantú A, Luviano-García JA, Jaime-Villalón D, Gutierrez-González D, Romero-Ibarguengoitia ME. Kuri-Ayache M, et al. Among authors: romero ibarguengoitia me. Front Immunol. 2023 Jan 4;13:1060840. doi: 10.3389/fimmu.2022.1060840. eCollection 2022. Front Immunol. 2023. PMID: 36685564 Free PMC article.
Effect of Heterologous Vaccination Regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG Antibodies Titers.
Romero-Ibarguengoitia ME, Rivera-Salinas D, Hernández-Ruíz YG, Armendariz-Vázquez AG, González-Cantú A, Barco-Flores IA, González-Facio R, Montelongo-Cruz LP, Del Rio-Parra GF, Sanz-Sánchez MÁ. Romero-Ibarguengoitia ME, et al. Vaccines (Basel). 2022 Mar 3;10(3):392. doi: 10.3390/vaccines10030392. Vaccines (Basel). 2022. PMID: 35335024 Free PMC article.
Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries.
Romero-Ibarguengoitia ME, González-Cantú A, Pozzi C, Levi R, Mollura M, Sarti R, Sanz-Sánchez MÁ, Rivera-Salinas D, Hernández-Ruíz YG, Armendariz-Vázquez AG, Del Rio-Parra GF, Barco-Flores IA, González-Facio R, Azzolini E, Barbieri R, de Azevedo Dias AR, Henriques Guimarães Júnior M, Bastos-Borges A, Acciardi C, Paez-Bo G, Teixeira MM, Rescigno M. Romero-Ibarguengoitia ME, et al. Front Immunol. 2022 Jul 28;13:894277. doi: 10.3389/fimmu.2022.894277. eCollection 2022. Front Immunol. 2022. PMID: 35967368 Free PMC article.
Analyzing the Interplay between COVID-19 Viral Load, Inflammatory Markers, and Lymphocyte Subpopulations on the Development of Long COVID.
Rivera-Cavazos A, Luviano-García JA, Garza-Silva A, Morales-Rodríguez DP, Kuri-Ayache M, Sanz-Sánchez MÁ, Santos-Macías JE, Romero-Ibarguengoitia ME, González-Cantú A. Rivera-Cavazos A, et al. Among authors: romero ibarguengoitia me. Microorganisms. 2023 Sep 6;11(9):2241. doi: 10.3390/microorganisms11092241. Microorganisms. 2023. PMID: 37764085 Free PMC article.
Temperature Differences Between Controlled Primary Hypothyroidism and Healthy Patients: An Exploratory Study.
Romero-Ibarguengoitia ME, Garza-Silva A, Rivera-Cavazos A, Morales-Rodriguez DP, González-Peña OI, Barco-Flores IA, Manilla-Muñoz E, Villarreal-Leal E, González-Cantú A. Romero-Ibarguengoitia ME, et al. J Endocr Soc. 2024 Jan 2;8(2):bvad175. doi: 10.1210/jendso/bvad175. eCollection 2024 Jan 5. J Endocr Soc. 2024. PMID: 38196662 Free PMC article.
Efficacy of Six Different SARS-CoV-2 Vaccines during a Six-Month Follow-Up and Five COVID-19 Waves in Brazil and Mexico.
Romero-Ibarguengoitia ME, Rivera-Salinas D, Sarti R, Levi R, Mollura M, Garza-Silva A, Rivera-Cavazos A, Hernández-Ruíz YG, Barco-Flores IA, González-Cantú A, Sanz-Sánchez MÁ, Guimarães Júnior MH, Pozzi C, Barbieri R, Morales-Rodriguez DP, Texeira MM, Rescigno M. Romero-Ibarguengoitia ME, et al. Vaccines (Basel). 2023 Apr 14;11(4):842. doi: 10.3390/vaccines11040842. Vaccines (Basel). 2023. PMID: 37112754 Free PMC article.
[Long-term efficacy of parathyroidectomy in secondary and tertiary hyperparathyroidism].
González-Cantú A, Romero-Ibarguengoitia ME, Quintanilla-Flores DL, Reza-Albarrán A, Herrera-Hernández M, Pantoja-Millán JP, Sierra-Salazar M, Velázquez-Fernández D, Gómez-Pérez FJ. González-Cantú A, et al. Among authors: romero ibarguengoitia me. Rev Med Inst Mex Seguro Soc. 2019 Dec 30;57(6):371-378. Rev Med Inst Mex Seguro Soc. 2019. PMID: 33001613 Spanish.
36 results